Andrew Chon

Andrew Chon is currently the Global Early Clinical Development Manager at Amgen, a position they have held since 2021. Prior to this, they served as a Clinical Research Manager for the Cancer Immunotherapy Program at the University of California, San Francisco from 2016 to 2021, and as a Clinical Research Associate at Stanford University from 2015 to 2016. Additionally, Andrew gained diverse experience as a Sales Associate at Banana Republic and worked in various roles related to research and development, including Laboratory Assistant at Pharmatek and Research Assistant at the University of Michigan. Andrew earned a Bachelor of Science in Pharmacological Chemistry from the University of California, San Diego, and studied Pre-Pharmacy at the University of Michigan.